Decoding fibrosis in nonresolvable COVID-19: a role for myeloid-specific HIF1A deletion
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00060.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Kemly Philip und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, Unit…. Hauptthemen laut MEDLINE: COVID-19, Hypoxia-Inducible Factor 1, alpha Subunit, Pulmonary Fibrosis, Myeloid Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), NHLBI NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Postviral-induced lung fibrosis represents a severe and potentially fatal outcome. This was most evident during the COVID-19 pandemic, where a subset of individuals presented with fulminant lung fibrosis requiring lung transplantation. The mechanisms that promote this exacerbated lung injury are not fully known. Herein, we demonstrate that mice lacking myeloid hypoxia-inducible factor 1A (HIF1A) develop an exacerbated lung injury response to bleomycin that was consistent with reduced macrophage HIF1A expression in nonresolvable (NR)-COVID-19, characterized by extensive lung fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, United States.
- Center for Advanced Cardiopulmonary Therapies and Transplantation, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, United States.
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, United States.
- Department of Pathology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, United States.
ORCID-Profile: Hannah P Thompson, Tingting W Mills, Harry Karmouty-Quintana
Förderung
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- NHLBI NIH HHS
- NIA NIH HHS
- NIAMS NIH HHS
- NCATS NIH HHS
Zitieren
APA
Philip, K., Thompson, H. P., Collum, S. D., Lefebvre, I., Akkanti, B., Zhao, B., Hussain, R., Patel, M., Blackburn, M. R., Mills, T. W., & Karmouty-Quintana, H. (2025). Decoding fibrosis in nonresolvable COVID-19: a role for myeloid-specific HIF1A deletion. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00060.2025
Vancouver
Philip K, Thompson HP, Collum SD, Lefebvre I, Akkanti B, Zhao B, et al. Decoding fibrosis in nonresolvable COVID-19: a role for myeloid-specific HIF1A deletion. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00060.2025
BibTeX
@article{Philip2025,
author = {Philip, Kemly and Thompson, Hannah P and Collum, Scott D and Lefebvre, Isabella and Akkanti, Bindu and Zhao, Bihong and Hussain, Rahat and Patel, Manish and Blackburn, Michael R and Mills, Tingting W and Karmouty-Quintana, Harry},
title = {Decoding fibrosis in nonresolvable COVID-19: a role for myeloid-specific HIF1A deletion},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00060.2025}
}
EUVIMED